コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 administration of carbidopa, an inhibitor of DOPA decarboxylase.
2 divergent from that of the homologous enzyme dopa decarboxylase.
3 rosine hydroxylase (TH), aromatic amino acid dopa decarboxylase (AADC), and GTP cyclohydrolase 1 (CH1
4 ions to that of nonspecific regions reflects DOPA decarboxylase activity and dopamine storage process
8 18F]DOPA in synaptic terminals, a measure of dopa decarboxylase activity, was quantified in regions r
9 duction of imidazole-4-acetate that involves dopa decarboxylase and a membrane-associated amine oxida
10 g Gpc4-mutant cells expressed high levels of DOPA decarboxylase and the dopamine transporter, two mar
11 maging of 6-[(18) F]fluorodopa (FD; reflects dopa decarboxylase) and [(11) C]dihydrotetrabenazine (DT
12 disease to investigate the applicability of dopa decarboxylase (DDC) activity measurements as useful
13 xylation of L-Dopa catalyzed by the enzyme L-Dopa decarboxylase (DDC) along with the corresponding un
15 he ERK sites in GRH are required to activate Dopa decarboxylase (Ddc) and misshapen (msn) epidermal w
16 such genes in Drosophila encode the enzymes dopa decarboxylase (Ddc) and tyrosine hydroxylase (ple).
17 melanogaster, tyrosine hydroxylase (TH) and dopa decarboxylase (DDC) are required for melanin synthe
19 ing Catsup the fourth locus found within the Dopa decarboxylase (Ddc) gene cluster that functions in
21 up-regulation of the arthropod melanin gene dopa decarboxylase (Ddc) in the absence of UV radiation
22 association of alleles and haplotypes at the DOPA decarboxylase (DDC) locus with the DSM-IV diagnosis
25 d in at least one endogenous transcript, the dopa decarboxylase (Ddc) pre-mRNA, which previously had
26 es of l-carbidopa, which is known to inhibit DOPA decarboxylase (DDC), a key protein in Parkinson's d
27 We identified one dopamine synthesis gene, DOPA decarboxylase (DDC), as a suppressor of tau toxicit
28 A sequences of tyrosine hydroxylase (TH) and dopa decarboxylase (DDC), two key enzymes in the biosynt
29 es affecting locomotor reactivity, including Dopa decarboxylase (Ddc), which catalyzes the final step
31 rotonin, and trace amines, relies in part on DOPA decarboxylase (DDC, AADC), an enzyme that is requir
33 used to demonstrate tyrosine hydroxylase, L-dopa decarboxylase, dopamine beta-hydroxylase, phenyleth
34 molecular mechanical (QM/MM) simulations of dopa decarboxylase have been carried out to elucidate th
36 llowing intra-accumbal administration of the DOPA decarboxylase inhibitor NSD 1015 through the microd
38 [along with the 3,4-dihydroxyphenylalanine (dopa) decarboxylase inhibitor NSD-1015, 100 mg/kg, 30 mi
40 ed nAMD with standard PD treatment of l-DOPA/DOPA-decarboxylase inhibitor or specific dopamine recept
42 Monoamine Oxidase (MAO); in flies, MAO-Like, Dopa Decarboxylase, Protein Kinase A and Glycogen Syntha
44 metabolism, (ii) carbidopa, an inhibitor of dopa decarboxylase which functions upstream of Abp1, plu
45 rkedly decreased by inhibition of the enzyme dopa decarboxylase, which converts (11)C-5-HTP to (11)C-